Course in Paediatric Oncology

About the Course:

The SIOP Europe Course in Paediatric Oncology is a unique 3-year long education and mentoring programme for fellows in paediatric haematology and oncology and junior faculty at academic medical centres across Europe and, exceptionally, non-European countries. It aims to support young and promising paediatric oncologists in the development of their careers.

The Course will take place annually and will consist of 3 modules, each lasting 4 days. Participants will attend one module per year and will receive CME accreditation per module and a SIOPE certificate after having completed all modules and passed a final exam.

The SIOPE Course offers a broad education and teaching on clinical aspects of childhood cancer, clinical research methods, research collaborations, statistical analysis, leadership, and how to manage the demands of family and career. It will, however, mostly focus on practical topics rather than theoretical topics including discussions of real-life cases and situations, patient management and how to perform clinical studies according to the current ethical and regulatory requirements.

The goal of the Course is to grow leading paediatric oncologists equipped with skills and ideas for high-quality patient management and clinical research in malignant haematology and oncology. The course will consist of short lectures and will include plenty of time for case discussions including “unforgettable cases”, quizzes and workshops.

Participants for Modules 1-3 (2022-2024) were already confirmed following a rigorous selection procedure. The application process for the next Modules (2025-2027) will open at the end of 2023.



A group of Fellows published a report about their experience in the first edition of the European Journal of Cancer: Paediatric Oncology, available here.


Course Chairs: 

  • Andishe Attarbaschi - Course Chair, SIOPE Board Member and St. Anna Children’s Hospital - Vienna, Austria
  • Reineke Schoot - Course Co-Chair, Young SIOPE Chair and Prinses Máxima Center for Pediatric Oncology - Utrecht, Netherlands


Contact Information:

If you are interested in attending future editions of the Course, or require further information, please send an email to:



Module 1: 6-9 April 2022 in Maasmechelen, Belgium

Following a rigorous selection procedure, 50 participants were selected on the quality of their applications to attend the first edition of the Course.

Due to the COVID-19 pandemic, the first module was initially postponed and then supplemented with a 2-Day Virtual Kick-Off Meeting which took place in March 2021.  

Module 1 took place on 6-9 April 2022 in Maasmechelen, Belgium. Faculty and participants gathered for 4 days of learning, exchanging ideas, working in groups, quizzes, mentorship, networking and a bit of fun! 

In small groups, participants discussed real-life cases and situations, as well as patient management. Topics such as genetic predisposition, nuclear medicine, communication with parents and patients, statistics, late effects, and essential medicines were also covered, as well as a highly entertaining talk on presentation skills. All sessions were extremely interactive and preliminary feedback from both participants and faculty was extremely positive.

The programme can be downloaded here.

The recordings of several sessions that took place during the Course are available on the SIOP Europe YouTube channel



Steering Committee:

  • Andishe Attarbaschi - Course Chair, SIOPE Board Member and St. Anna Children’s Hospital - Vienna, Austria
  • Reineke Schoot - Course Co-Chair, Young SIOPE Chair and Prinses Máxima Center for Pediatric Oncology - Utrecht, Netherlands
  • Francesco Ceppi - Lausanne University Hospital - Lausanne, Switzerland
  • Jelena Lazic - University Children's Hospital - Belgrade, Serbia
  • Hans Merks - Prinses Máxima Center for Pediatric Oncology - Utrecht, Netherlands
  • Veronique Minard - Institut Gustave Roussy - Paris, France
  • Carmelo Rizzari - SIOPE CRC Chair, SIOPE President Elect and University of Milano-Bicocca - Milan, Italy
  • Carina Schneider - CCI-Europe Patient Representative - Vienna, Austria
  • Martin Schrappe - SIOPE Past President and University Hospital Schleswig-Holstein - Kiel, Germany
  • Lewis Silverman - Dana-Farber Cancer Institute - Boston, MA, USA
  • Jan Stary - University Hospital Motol - Prague, Czech Republic
  • Roelof van Ewijk - Young SIOPE and Prinses Máxima Center for Pediatric Oncology - Utrecht, Netherlands

Module 2: 7-10 June 2023 in Ljubljana, Slovenia

Module 2 of the SIOP Europe Course in Paediatric Oncology will take place 7-10 June in Ljubljana, Slovenia.

Participants will work in small working groups on several cases, including medulloblastoma, allo-SCT in ALL, HGG, and CART in ALL. There will be sessions on cytomorphology of malignant diseases, diagnostics and therapeutics in histiocytic disorders, molecular diagnostics, palliation, and practical sessions on communication and preparation of publications. Participants will receive feedback and guidance from mentors throughout the module.

The final programme is available HERE.

For practical information and questions, please e-mail

Participation Fee

In order to attend the SIOP Europe Course in Paediatric Oncology, all selected participants will be required to pay the Participation Fee.

The Participation Fee is 625 EUR plus VAT. It includes:

  • Access to all Course sessions and Course material;
  • Access to and mentoring by highly experienced experts in oncology;
  • Shared accommodation at the Course venue;
  • Food and beverages throughout the duration of the Course;
  • Social activities organised as part of the Course.

Please note: Travel expenses are NOT covered by the registration fee. Travel grants may be granted on a case by case basis.

Reimbursement policy

SIOPE Course in Paediatric Oncology Module 2 (7-10 June 2023)

  • 28 February 2023 - fee payment deadline. ‚Äč
  • If you cancel your participation before 28 March 2023, you will receive a 50% refund.
  • Cancellations received after 28 March 2023 are not eligible for refund.